The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Nicotine Transdermal Patch and Atypical Antipsychotic Medications for Smoking Cessation in Schizophrenia
Abstract
OBJECTIVE: Schizophrenic patients have high rates of cigarette smoking. The authors compared the outcomes of two group psychotherapy programs for smoking cessation in patients with schizophrenia or schizoaffective disorder who were also treated with the nicotine transdermal patch and with either atypical or typical antipsychotic medications. METHOD: Forty-five subjects were randomly assigned to 1) the group therapy program of the American Lung Association (N=17) or 2) a specialized group therapy program for smokers with schizophrenia (N=28) that emphasized motivational enhancement, relapse prevention, social skills training, and psychoeducation. All subjects participated in 10 weeks of treatment with the nicotine transdermal patch (21 mg/day) and 10 weekly group therapy sessions and continued to receive their prestudy atypical (N=18) or typical (N=27) antipsychotic medications. Outcome variables included treatment retention, rate of smoking abstinence, and expired-breath carbon monoxide level. RESULTS: Smoking abstinence rates did not differ in the two group therapy programs. However, atypical antipsychotic agents, in combination with the nicotine transdermal patch, significantly enhanced the rate of smoking cessation (55.6% in the atypical agent group versus 22.2% in the typical group), which was reflected by a significant effect of atypical versus typical agents on carbon monoxide levels. Risperidone and olanzapine were associated with the highest quit rates. CONCLUSIONS: The results suggest that 1) smoking cessation rates with the nicotine transdermal patch are modest in schizophrenia, 2) specialized group therapy for schizophrenic patients is not significantly different from American Lung Association group therapy in its effect on smoking cessation, and 3) atypical agents may be superior to typical agents in combination with the nicotine transdermal patch for smoking cessation in schizophrenia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
An inventory for measuring depression
BECK, A. T. (1961) · Archives of General Psychiatry · doi:10.1001/archpsyc.1961.01710120031004 · Cited by 38,032
The Positive and Negative Syndrome Scale (PANSS) for schizophrenia.
Kay, S. R., Fiszbein, A., & Opler, L. A. (1987) · Schizophrenia Bulletin · doi:10.1093/schbul/13.2.261 · Cited by 21,378
The Fagerstrom Test for Nicotine Dependence: a revision of the Fagerstrom Tolerance Questionnaire
HEATHERTON, T. F., KOZLOWSKI, L. T., FRECKER, R. C., & FAGERSTROM, K. (1991) · British Journal of Addiction · doi:10.1111/j.1360-0443.1991.tb01879.x · Cited by 10,738
Stages and processes of self-change of smoking: Toward an integrative model of change.
Prochaska, J. O., & DiClemente, C. C. (1983) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.51.3.390 · Cited by 9,098
(1991) · Medical Entomology and Zoology · Cited by 4,438
Application of hierarchical linear models to assessing change.
Bryk, A. S., & Raudenbush, S. W. (1987) · Psychological Bulletin · doi:10.1037//0033-2909.101.1.147 · Cited by 1,514
Survival probabilities (the Kaplan-Meier method)
Bland, J. M., & Altman, D. G. (1998) · BMJ · doi:10.1136/bmj.317.7172.1572 · Cited by 824
Gibbons, R. D. (1993) · Archives of General Psychiatry · doi:10.1001/archpsyc.1993.01820210073009 · Cited by 719
Smoking withdrawal symptoms in two weeks of abstinence
Shiffman, S. M., & Jarvik, M. E. (1976) · Psychopharmacology · doi:10.1007/bf00634151 · Cited by 540
Nicotine Dependence in Schizophrenia: Clinical Phenomena and Laboratory Findings
Dalack, G. W., Healy, D. J., & Meador-Woodruff, J. H. (1998) · American Journal of Psychiatry · doi:10.1176/ajp.155.11.1490 · Cited by 498
Swerdlow, N. R., Caine, S. B., Braff, D. L., & Geyer, M. A. (1992) · Journal of Psychopharmacology · doi:10.1177/026988119200600210 · Cited by 388
Schizophrenia: A Life-shortening Disease
Allebeck, P. (1989) · Schizophrenia Bulletin · doi:10.1093/schbul/15.1.81 · Cited by 335
Kelly, C., & McCreadie, R. G. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.11.1751 · Cited by 317
Ziedonis, D. M., & George, T. P. (1997) · Schizophrenia Bulletin · doi:10.1093/schbul/23.2.247 · Cited by 278
Self-citationSmoking Cessation Treatment for Patients With Schizophrenia
Addington, J., el-Guebaly, N., Campbell, W., Hodgins, D. C., & Addington, D. (1998) · American Journal of Psychiatry · doi:10.1176/ajp.155.7.974 · Cited by 229
Haloperidol increases smoking in patients with schizophrenia
McEvoy, J. P., Freudenreich, O., Levin, E. D., & Rose, J. E. (1995) · Psychopharmacology · doi:10.1007/bf02246063 · Cited by 225
Gating of auditory P50 in schizophrenics: Unique effects of clozapine
Nagamoto, H. T., Adler, L. E., Hea, R. A., Griffith, J. M., McRae, K. A., & Freedman, R. (1996) · Biological Psychiatry · doi:10.1016/0006-3223(95)00371-1 · Cited by 201
Clozapine decreases smoking in patients with chronic schizophrenia
McEvoy, J., Freudenreich, O., McGee, M., Vanderzwaag, C., Levin, E., & Rose, J. (1995) · Biological Psychiatry · doi:10.1016/0006-3223(94)00365-a · Cited by 195
Balfour, D. J. K., & Fagerström, K. O. (1996) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(96)00099-x · Cited by 195
Effects of clozapine on smoking in chronic schizophrenic outpatients.
George, T. P., Sernyak, M. J., Ziedonis, D. M., & Woods, S. W. (1995) · PubMed · Cited by 179
Self-citationThe incidence of cancer in schizophrenic patients.
Mortensen, P. B. (1989) · Journal of Epidemiology and Community Health · doi:10.1136/jech.43.1.43 · Cited by 175
Smoking and therapeutic response to clozapine in patients with schizophrenia
McEvoy, J. P., Freudenreich, O., & Wilson, W. H. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(98)00377-1 · Cited by 172
Andersen, K., Balldin, J., Gottfries, C. G., Granérus, A.-K., Modigh, K., Svennerholm, L., & Wallin, A. (1987) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1987.tb03566.x · Cited by 169
Martin, J. E., Calfas, K. J., Patten, C. A., & Polarek, M. (1997) · Journal of Consulting and Clinical Psychology · doi:10.1037//0022-006x.65.1.190 · Cited by 168
Ziedonis, D. M., & Trudeau, K. (1997) · Schizophrenia Bulletin · doi:10.1093/schbul/23.2.229 · Cited by 162
Self-citationBuckley, P. F., Thompson, P., Way, L. E., & Meltzer, H. Y. (1994) · American Journal of Psychiatry · doi:10.1176/ajp.151.3.385 · Cited by 148
Nicotine Withdrawal and Psychiatric Symptoms in Cigarette Smokers with Schizophrenia
Dalack, G. W., Becks, L., Hill, E., Pomerleau, O. F., & Meador-Woodruff, J. H. (1999) · Neuropsychopharmacology · doi:10.1016/s0893-133x(98)00121-3 · Cited by 133
Kumari, V., Checkley, S. A., & Gray, J. A. (1996) · Psychopharmacology · doi:10.1007/s002130050109 · Cited by 122
Readiness to Stop Smoking in Schizophrenia
Addington, J., el‐Guebaly, N., Addington, D. E., & Hodgins, D. C. (1997) · The Canadian Journal of Psychiatry · doi:10.1177/070674379704200107 · Cited by 112
Contingency management for tobacco smoking in methadone-maintained opiate addicts
SHOPTAW, S. J., Jarvik, M. E., Ling, W. W., & Rawson, R. A. (1996) · Addictive Behaviors · doi:10.1016/0306-4603(95)00066-6 · Cited by 103
Decreased substance use in chronically psychotic patients treated with clozapine
Albanese, M., Khantzian, E. J., Murphy, S. L., et al. (1994) · American Journal of Psychiatry · doi:10.1176/ajp.151.5.780b · Cited by 92
Roll, J. M., Higgins, S. T., Steingard, S., & McGinley, M. (1998) · Experimental and Clinical Psychopharmacology · doi:10.1037//1064-1297.6.2.157 · Cited by 88
Subjective experience and mental side‐effects of antipsychotic treatment
Gerlach, J., & Larsen, E. B. (1999) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1999.tb05990.x · Cited by 84
Group Treatment for Smoking Cessation Among Persons With Schizophrenia
Addington, J. (1998) · Psychiatric Services · doi:10.1176/ps.49.7.925 · Cited by 76
George, T. P., Verrico, C. D., & Roth, R. H. (1998) · Brain Research · doi:10.1016/s0006-8993(98)00537-x · Cited by 44
Self-citationTreatment of neuroleptic-induced akathisia with nicotine patches
Anfang, M. K., & Pope, H. G. (1997) · Psychopharmacology · doi:10.1007/s002130050436 · Cited by 38
Contingent reinforcement for reduced carbon monoxide levels in methadone maintenance patients
Schmitz, J. M., Rhoades, H. M., & Grabowski, J. G. (1995) · Addictive Behaviors · doi:10.1016/0306-4603(94)00059-x · Cited by 34
George, T. P., Verrico, C. D., Xu, L., & Roth, R. H. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(99)00165-7 · Cited by 31
Self-citationAn assessment of nicotine gum as an adjunct to freedom from smoking cessation clinics
McGovern, P. G., & Lando, H. A. (1992) · Addictive Behaviors · doi:10.1016/0306-4603(92)90018-q · Cited by 17
Bupropion and Smoking Cessation
Evins, A. E., & Tisdale, T. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.5.798a · Cited by 16
Treatment of Nicotine Dependence in the Chronic Mentally Ill
Rosen-Chase, C., & Dyson, V. (1999) · Journal of Substance Abuse Treatment · doi:10.1016/s0740-5472(98)00077-4 · Cited by 13
Cited by
Schizophrenia and increased risks of cardiovascular disease
Hennekens, C. H., Hennekens, A. R., Hollar, D., & Casey, D. E. (2005) · American Heart Journal · doi:10.1016/j.ahj.2005.02.007 · Cited by 1,070
The 2009 Schizophrenia PORT Psychopharmacological Treatment Recommendations and Summary Statements
Buchanan, R. W., Kreyenbuhl, J., Kelly, D. L., Noel, J. M., Boggs, D. L., Fischer, B. A., Himelhoch, S., Fang, B., Peterson, E., Aquino, P. R., et al. (2010) · Schizophrenia Bulletin · doi:10.1093/schbul/sbp116 · Cited by 907
DE HERT, M., COHEN, D., BOBES, J., CETKOVICH‐BAKMAS, M., LEUCHT, S., NDETEI, D. M., NEWCOMER, J. W., UWAKWE, R., ASAI, I., MÖLLER, H., et al. (2011) · World Psychiatry · doi:10.1002/j.2051-5545.2011.tb00036.x · Cited by 870
Antipsychotic Drugs: Prolonged QTc Interval, Torsade de Pointes, and Sudden Death
Glassman, A. H., & Bigger, J. T. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.11.1774 · Cited by 822
Group behaviour therapy programmes for smoking cessation
Stead, L. F., Carroll, A. J., & Lancaster, T. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001007.pub3 · Cited by 781
Metadata
- Authors
- George, T. P., Ziedonis, D. M., Feingold, A., Pepper, W. T., Satterburg, C. A., Winkel, J., Rounsaville, B. J., & Kosten, T. R.
- Venue
- American Journal of Psychiatry
- Published
- 2000-11-01
- Volume
- 157
- Issue
- 11
- Pages
- 1835-1842
- ISSN
- 0002-953X (ISSN-L)
- 1535-7228
- OpenAlex
- W2115487888
- Cited by
- 354
- References
- 41
- FWCI
- 7.94
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.